| Product Code: ETC10939584 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Malta vaccine import shipments in 2024 show a continued reliance on key European suppliers such as the UK, Germany, Italy, Netherlands, and Spain. Despite high concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a modest compound annual growth rate (CAGR) of 2.77% from 2020 to 2024. However, there was a significant decline in growth from 2023 to 2024, with a rate of -50.11%. Monitoring these trends can provide valuable insights for stakeholders in the vaccine import market in Malta.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Vaccine Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Vaccine Market - Industry Life Cycle |
3.4 Malta Vaccine Market - Porter's Five Forces |
3.5 Malta Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malta Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Malta Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Malta Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Malta Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Malta Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malta Vaccine Market Trends |
6 Malta Vaccine Market, By Types |
6.1 Malta Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Malta Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Malta Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Malta Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Malta Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Malta Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Malta Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Malta Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Malta Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Malta Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Malta Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Malta Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Malta Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Malta Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Malta Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Malta Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Malta Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Malta Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Malta Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Malta Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Malta Vaccine Market Import-Export Trade Statistics |
7.1 Malta Vaccine Market Export to Major Countries |
7.2 Malta Vaccine Market Imports from Major Countries |
8 Malta Vaccine Market Key Performance Indicators |
9 Malta Vaccine Market - Opportunity Assessment |
9.1 Malta Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malta Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Malta Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Malta Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Malta Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Malta Vaccine Market - Competitive Landscape |
10.1 Malta Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Malta Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here